FLUIDIGM CORPORATION (NASDAQ:FLDM) Files An 8-K Other EventsItem 8.01 Other Events.
In accordance with the Company’s bylaws, for director nominations or stockholder proposals to be brought before the upcoming annual meeting of stockholders, other than Rule14a-8 proposals described above, written notice must be delivered no later than March 2, 2018by mailing such proposals to Corporate Secretary, Fluidigm Corporation, 7000 Shoreline Court, Suite 100, South San Francisco, California 94080. Such notices must also comply with the requirements of the Company’s bylaws and other applicable law, and no director nomination or stockholder proposal may be presented at the annual meeting otherwise.
About FLUIDIGM CORPORATION (NASDAQ:FLDM)
Fluidigm Corporation creates, manufactures and markets technologies and life science tools focused on the exploration and analysis of single cells, as well as the industrial application of genomics, based upon the Company’s core microfluidics and mass cytometry technologies. The Company operates in the development, manufacturing and commercialization of life science tools for the life science and Ag-Bio industries segment. Its products include preparatory instruments, preparatory analytical instruments, analytical instruments, integrated fluidic circuits (IFCs), and assays and reagents. Its preparatory instruments include C1 Single-Cell Auto Prep System, Access Array System, Juno System and IFCs, and Callisto System and IFC. Its analytical instruments include Biomark HD System, EP1 System and Helios/CyTOF 2 System. Its assays and reagents include Delta Gene and SNP Type Assays, and Access Array Target-Specific Primers and Targeted Sequencing Prep Primers.